Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant small » significant male (Expand Search), significant all (Expand Search), significant shape (Expand Search)
small decrease » small increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant small » significant male (Expand Search), significant all (Expand Search), significant shape (Expand Search)
small decrease » small increased (Expand Search)
-
2201
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2202
-
2203
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2204
-
2205
-
2206
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2207
-
2208
-
2209
-
2210
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2211
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2212
-
2213
-
2214
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2215
-
2216
-
2217
-
2218
-
2219
-
2220